Molecular diagnostics and the training of future tissue- and cell-based pathologists

Cytopathology

Volumn 23, Issue 5, 2012, Pages 283-285

  Catherwood, M A ^a,b   Schmitt, F ^c   Salto Tellez, M ^a,b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c University of Porto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOGLOBULIN; K RAS PROTEIN; T LYMPHOCYTE RECEPTOR;

CHROMOSOME ABERRATION; CLINICAL LABORATORY; CLINICAL PRACTICE; COLON CANCER; CYTODIAGNOSIS; CYTOLOGY; DRUG TARGETING; EDITORIAL; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN GENE; LABORATORY DIAGNOSIS; LEUKEMIA; LUNG CANCER; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MEDICAL SPECIALIST; MOLECULAR BIOLOGY; MOLECULARLY TARGETED THERAPY; PATHOLOGIST; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR GENE; SARCOMA; STAFF TRAINING; TREATMENT RESPONSE; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; UNITED KINGDOM;

HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASMS; PATHOLOGY, MOLECULAR; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84866500966     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12015     Document Type: Editorial

References (12)

1. Watson JD, Crick FH. Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 1953;171:737-8.
2. Lander ES, Linton LM, Birren B et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
3. Quek TPL, Yan B, Yong WP, Salto-Tellez M. Targeted therapeutics-oriented tumor classification: a paradigm shift. Per Med 2009;6:465-8.
4. Salto-Tellez M. A case for integrated morphomolecular diagnostic pathologists. Clin Chem 2007;53:1188-90.
5. Salto-Tellez M, Koay ESC. Molecular diagnostic cytopathology - definitions, scope and clinical utility. Cytopathology 2004;15:252-5.
6. Schmitt F, Barroca H. Role of ancillary techniques in fine-needle aspiration from selected tumors. Cancer Cytopathol 2012;120:145-60.
7. Boyd C, Boyle DP. Molecular Diagnosis on Tissues and Cells: how it affects practice and will do in the future. Cytopathology 2012;23:286-94.
8. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009;458:719-24.
9. Di Lorito A, Schmitt FC. (Cyto)pathology and sequencing: next (or last) generation? Diagn Cytopathol 2012;40:459-61.
10. Lauwers GY, Black-Schaffer S, Salto-Tellez M. Molecular pathology in contemporary diagnostic pathology laboratory: an opinion for the active role of surgical pathologists. Am J Surg Pathol 2010;34:115-7.
11. Berman DM, Bosenberg MW, Orwant RL et al. Investigative pathology: leading the post-genomic revolution. Lab Invest 2012;92:4-8.
12. Tötsch M, Fassina A, Vass L, Cuvelier C. Requirement for recognition of post-graduate training in pathology. Board of Pathology-UEMS. Cytopathology 2012;23:295-9.